Barrington Research Raises Franklin Covey (NYSE:FC) Price Target to $25.00

Franklin Covey (NYSE:FC) had its price objective lifted by Barrington Research from $22.00 to $25.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has an “outperform” rating on the business services provider’s stock. Barrington Research’s price target points to a potential upside of 18.64% from the stock’s previous close.

Separately, Weiss Ratings reissued a “sell (d+)” rating on shares of Franklin Covey in a report on Friday, October 31st. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $26.00.

Franklin Covey Trading Up 0.1%

NYSE FC opened at $21.07 on Tuesday. The stock has a market capitalization of $243.38 million, a price-to-earnings ratio of -175.59, a PEG ratio of 1.28 and a beta of 0.66. The stock has a 50-day moving average of $16.73 and a 200 day moving average of $18.22. Franklin Covey has a twelve month low of $14.03 and a twelve month high of $39.22.

Franklin Covey (NYSE:FC) last issued its quarterly earnings data on Wednesday, January 7th. The business services provider reported ($0.27) EPS for the quarter, missing the consensus estimate of $0.03 by ($0.30). The business had revenue of $64.05 million during the quarter, compared to analyst estimates of $64.77 million. Franklin Covey had a negative net margin of 0.54% and a positive return on equity of 9.98%. During the same period in the previous year, the business posted $0.20 earnings per share. Equities analysts predict that Franklin Covey will post 0.97 EPS for the current fiscal year.

Insider Activity

In related news, insider Michael Sean Merrill Covey sold 7,000 shares of the business’s stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $14.68, for a total transaction of $102,760.00. Following the completion of the sale, the insider directly owned 218,636 shares in the company, valued at approximately $3,209,576.48. The trade was a 3.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 15.20% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Franklin Covey

Several institutional investors and hedge funds have recently added to or reduced their stakes in FC. Wiser Advisor Group LLC purchased a new stake in shares of Franklin Covey during the third quarter worth $35,000. CWM LLC grew its stake in Franklin Covey by 81.8% during the 3rd quarter. CWM LLC now owns 1,983 shares of the business services provider’s stock valued at $38,000 after acquiring an additional 892 shares in the last quarter. Amundi acquired a new stake in Franklin Covey in the 1st quarter valued at about $58,000. BNP Paribas Financial Markets lifted its stake in Franklin Covey by 98.9% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,236 shares of the business services provider’s stock worth $43,000 after purchasing an additional 1,112 shares in the last quarter. Finally, Quarry LP acquired a new position in shares of Franklin Covey during the 3rd quarter worth approximately $74,000. Institutional investors and hedge funds own 69.88% of the company’s stock.

About Franklin Covey

Franklin Covey Co (NYSE:FC) is a global consulting and training firm specializing in performance improvement solutions for individuals and organizations. The company offers a range of services, including leadership development, productivity tools, execution frameworks and assessments designed to foster personal effectiveness and drive business results. Its flagship offerings integrate training workshops, digital resources and coaching to support clients in areas such as strategic planning, team productivity and change management.

The origins of Franklin Covey trace back to the merger in 1997 of Franklin Quest Co, founded in 1983 by Hyrum W.